Skip to main content
Clinical Trials/NL-OMON24642
NL-OMON24642
Recruiting
Not Applicable

A Prospective Observational Study of Treatment Options in Men with metastatic hormone sensitive prostate cancer (mHSPC)

Janssen-Cilag B.V.0 sites450 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ewly diagnosed metastatic hormone sensitive prostate cancer
Sponsor
Janssen-Cilag B.V.
Enrollment
450
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male, 18 years or older aged
  • Must have a confirmed newly diagnosis of metastatic hormone sensitive prostate cancer.
  • Must sign a participation agreement/ICF allowing data collection and source data verification in accordance with local requirements

Exclusion Criteria

  • Currently enrolled in an investigational interventional study
  • Currently enrolled in an observational study sponsored or managed by a Janssen company
  • Patients with insufficient understanding of the Dutch language or cognitive impairment that impede proper answering of the questionnaires

Outcomes

Primary Outcomes

Not specified

Similar Trials